LiCor Odyssey CLx Infrared Imaging System

Added: Mar 21, 2017 4:04 pm This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with LiCor Inc, Lincoln, NE to procure a Odyssey CXL Infrared Imaging System.

The Odyssey CXL Infrared Imaging System will be used in support of ongoing research at the Laboratory of Allergic Diseases (LAD) to investigate cellular and biochemical pathways responsible for the symptoms characteristics of LDS and other allergic diseases. Place of delivery is Bethesda, MD 20892.

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-RML-D-1841032) to Skye Duffner at skye.duffner@nih.gov, by 5:00 pm eastern standard time Wednesday, April 4, 2017. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.